We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00034528
Recruitment Status : Terminated (Due to slow recruitment)
First Posted : May 1, 2002
Last Update Posted : May 1, 2013
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)